“…The mechanisms by which PGG exerts its anticancer effects include an increase in oxidative stress, arresting the proliferation of abnormally growing cells at cell cycle checkpoints, enhanced autophagy and apoptosis of cancer cells, and inhibition of angiogenesis and metastasis. The potential therapeutic targets of PGG are transcription factors, namely STAT3 [ 40 , 45 , 61 ] and NF-κB [ 24 , 39 , 44 , 72 , 73 , 74 ], and growth factors, including vascular endothelial growth factor (VEGF; the primary target) [ 48 , 75 , 76 , 77 ]. PGG has anti-inflammatory activity, and its principal therapeutic targets are TNF-a [ 38 , 78 , 79 , 80 , 81 , 82 , 83 ], interferons [ 74 , 83 , 84 , 85 ], interleukins [ 78 , 80 , 82 , 83 , 84 , 85 , 86 ], and MCP-1 [ 79 , 80 , 87 ].…”